Guanhao Biotech (300238) Stock Overview

Guanhao Biotech Co.,Ltd. develops, manufactures, and markets regenerative medicines and life sciences products in China. It offers NormalGEN, a dura repair patch; GrandNeuro, a dura repair patch; ThormalGEN, a surgical patch; DermalGEN, a wound dressing product; IREAL breast patch; and Youvision corneal graft, as well as license in intraocular lenses. Its products can be used in neurosurgery, thoracic surgery, ophthalmology, dermatology, orthopedics, cosmetology, and other areas. The company was founded in 1999 and is headquartered in Guangzhou, China.